Grand Pharmaceutical GroupCGPHF 87 FCF Yield % is 0.80 as of Jun. 27, 2026, which is 85% below its 10-year median of 5.26. GuruFocus rates CGPHF with a GF Score™ of 87/100. The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 51.34% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Grand Pharmaceutical Group FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Grand Pharmaceutical Group FCF Yield % Related Terms
Grand Pharmaceutical Group FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Pharmaceutical Group (CGPHF) has a FCF Yield % of 0.80 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Grand Pharmaceutical Group and its competitors. This is 85% below median its historical median of 5.26. Over the past decade, Grand Pharmaceutical Group's FCF Yield % has ranged from 0.46 to 16.50. According to the industry distribution chart, Grand Pharmaceutical Group ranks #489 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 48.7%.
Is Grand Pharmaceutical Group's FCF Yield % too high?
Grand Pharmaceutical Group's current FCF Yield % of 0.80 is 85% below median its 10-year median of 5.26. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 16.50. The Drug Manufacturers industry median FCF Yield % is 0.67. Grand Pharmaceutical Group's value of 0.80 is 19.4% above this industry median. Based on the distribution chart, Grand Pharmaceutical Group ranks #489 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grand Pharmaceutical Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #489 out of 1005 companies for FCF Yield %. This puts Grand Pharmaceutical Group in the upper half of its industry. The industry median FCF Yield % is 0.67. Grand Pharmaceutical Group's value of 0.80 is 19.4% above this benchmark. Historically, Grand Pharmaceutical Group's own FCF Yield % has ranged from 0.46 to 16.50 over the past decade. While the company's 10-year median is 5.26 vs. the industry median of 0.67, Grand Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Pharmaceutical Group's current FCF Yield % of 0.80 is 19.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current FCF Yield % is 0.80, which is 85% below median its own 10-year median of 5.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current FCF Yield % of 0.80. The current FCF Yield % is 0.80, which is 85% below median its 10-year median of 5.26 and 19.4% above the Drug Manufacturers industry median of 0.67. Grand Pharmaceutical Group's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current FCF Yield % is 0.80 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGPHF has been successfully added to your 